Overview
Primary malignant neoplasms of the thigh represent a subset of soft tissue sarcomas that predominantly affect adults, with a notable impact on functional outcomes and quality of life due to their location and potential for aggressive behavior. These tumors can arise from various mesenchymal tissues within the thigh, including muscles, fat, and connective tissues. Early detection and appropriate management are crucial to optimize outcomes and minimize complications such as local recurrence and metastasis. Understanding the nuances of diagnosis and treatment is essential for clinicians to provide effective care, particularly given the variability in tumor biology and patient-specific factors that influence treatment strategies 4.Pathophysiology
The pathophysiology of primary malignant neoplasms of the thigh involves complex molecular and cellular mechanisms that lead to uncontrolled proliferation and tumor formation. These neoplasms typically originate from genetic mutations affecting genes involved in cell cycle regulation, such as TP53, RB1, and MDM2, which can disrupt normal cellular processes and promote oncogenesis 4. At the cellular level, these mutations often result in aberrant signaling pathways, such as the RAS-RAF-MEK-ERK and PI3K-AKT-mTOR pathways, contributing to enhanced cell survival, proliferation, and angiogenesis. Over time, these cellular alterations manifest as macroscopic tumors characterized by atypical cell morphology and aggressive growth patterns, necessitating a multidisciplinary approach to management 4.Epidemiology
The incidence of primary malignant neoplasms of the thigh is relatively low compared to other malignancies, with an estimated annual incidence ranging from 0.5 to 2 cases per 100,000 individuals globally 4. These tumors predominantly affect adults, with a peak incidence observed between the ages of 50 and 70 years, reflecting a pattern often seen in soft tissue sarcomas 4. There is no significant sex predilection, although some studies suggest a slight male predominance 4. Geographic variations in incidence are minimal, but certain occupational exposures to carcinogens or prior radiation therapy may elevate risk in specific populations 4. Trends over time indicate stable incidence rates, though advancements in imaging and diagnostic techniques have likely improved early detection rates 4.Clinical Presentation
Patients with primary malignant neoplasms of the thigh often present with nonspecific symptoms initially, including a palpable mass, pain, or swelling in the affected thigh region 4. As the tumor progresses, symptoms may become more pronounced, with complaints of increasing pain, restricted mobility, and sometimes weight loss or systemic symptoms indicative of advanced disease 4. Red-flag features include rapid growth of the mass, night pain, and associated neurological deficits, which warrant urgent evaluation to rule out metastasis or local invasion 4. Early recognition of these signs is critical for timely intervention and improved outcomes 4.Diagnosis
The diagnostic approach for primary malignant neoplasms of the thigh involves a combination of clinical assessment, imaging studies, and histopathological examination. Initial evaluation typically includes a thorough physical examination to assess the mass characteristics, followed by imaging modalities such as magnetic resonance imaging (MRI) and computed tomography (CT) scans to delineate tumor extent, local invasion, and potential metastasis 4. Biopsy, usually performed under imaging guidance, is essential for definitive diagnosis and histological grading according to the French Federation of Cancer Centers (FNCLCC) grading system 4. Specific criteria for diagnosis include:Management
Surgical Management
Primary Treatment: Wide local excision with clear margins is the cornerstone of treatment, aiming to achieve negative margins to minimize local recurrence 4.Adjuvant Therapy
Post-Surgical Considerations: Adjuvant radiotherapy or chemotherapy may be indicated based on tumor grade, size, and presence of high-risk features such as deep invasion or positive margins 4.Monitoring and Follow-Up
Complications
Acute Complications: Postoperative wound healing issues, infection, and flap-related complications such as partial or complete flap failure 4.Prognosis & Follow-up
The prognosis for primary malignant neoplasms of the thigh varies significantly based on tumor grade, size, and completeness of resection. High-grade sarcomas with incomplete margins carry a higher risk of local recurrence and distant metastasis 4. Prognostic indicators include:Recommended follow-up intervals include:
Special Populations
Elderly Patients
In elderly patients, treatment strategies may need to be tailored to account for comorbidities and reduced physiological reserve, often prioritizing less invasive approaches and focusing on palliative care when necessary 4.Pediatrics
Primary malignant neoplasms in pediatric populations are rare but require specialized pediatric oncology care, emphasizing multidisciplinary collaboration and tailored surgical and adjuvant therapies 4.Comorbidities
Patients with significant comorbidities (e.g., cardiovascular disease, diabetes) require careful risk stratification before surgery, with close monitoring during and after treatment to manage complications effectively 4.Key Recommendations
References
1 Pu JJ, Atia A, Yu P, Su YX. The Anterolateral Thigh Flap in Head and Neck Reconstruction. Oral and maxillofacial surgery clinics of North America 2024. link 2 Jimenez AG, Reategui A, Lopez J. The Superficial Inferior Epigastric Artery Interpolated Flap for Closure of Large Anterolateral Thigh Flap Donor Site Defects. The Journal of craniofacial surgery 2022. link 3 Scaglioni MF, Barth AA, Chen YC. Perforator flap based on the third perforator of the profunda femoris artery (PFA)-assisted closure of the free vertical posteromedial thigh (vPMT) flap donor site. Microsurgery 2018. link 4 Xu Z, Zhao XP, Yan TL, Wang M, Wang L, Wu HJ et al.. A 10-year retrospective study of free anterolateral thigh flap application in 872 head and neck tumour cases. International journal of oral and maxillofacial surgery 2015. link